Disclosures for "Medicare Part D Utilization, Spending, and Formulary Coverage of Brand-name Disease Modifying Therapies with Generics Available for Multiple Sclerosis"
-
Dr. Li has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cobbs Creek Healthcare . Dr. Li has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for SKB Consulting Inc.
-
The institution of Dr. Klebanoff has received research support from HRSA.
-
Dr. Lin has nothing to disclose.
-
Miss Doshi has nothing to disclose.
-
Dr. Chahin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Chahin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Chahin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutic . The institution of Dr. Chahin has received research support from National MS Society. The institution of Dr. Chahin has received research support from BMS.
-
Dr. Doshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck & Co., Inc. Dr. Doshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen Global Services, LLC. Dr. Doshi has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Abbvie. Dr. Doshi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. The institution of Dr. Doshi has received research support from Janssen Scientific Affairs, LLC. The institution of Dr. Doshi has received research support from Merck & Co., Inc. The institution of Dr. Doshi has received research support from Spark Therapeutics.